4 articles
The new vaccine shows 82% efficacy against all malaria strains and requires only a single dose. Mass distribution to begin in sub-Saharan Africa by September.
Researchers at AIIMS New Delhi and the Mayo Clinic have announced successful results from a Phase II clinical trial of a gene therapy that effectively reversed ...
The World Health Organization has declared the end of the latest mpox outbreak that affected 47 countries over 18 months. The successful containment was attribu...
All 45 patients in the Phase 3 trial showed complete remission after a single CRISPR gene editing treatment. FDA approval expected by year-end.